INFLIXIMAB Side Effects

7023526-3 | Cellulitis, Lymphadenopathy, Nausea, Pain In Extremity, Pyrexia, Rash, Swelling
on Sep 29, 2010 Male patient from UNITED STATES , 57 years of age, weighting 138.9 lb, was diagnosed with psoriatic arthropathy and was treated with Infliximab (View Usage). Patient experienced the following unwanted or unexpected effects: cellulitis (What is cellulitis?), lymphadenopathy, nausea (What is nausea?), pain in extremity, pyrexia, rash (What is rash?), swelling. Infliximab dosage: 300 Mg Other Iv. Patient was hospitalized.

7014671-7 | Acute Lymphocytic Leukaemia, B-cell Lymphoma
Patient was taking Infliximab (View Usage). Patient had the following side effects: acute lymphocytic leukaemia, b-cell lymphoma on Sep 16, 2010 from UNITED KINGDOM Additional patient health information: Male patient , weighting 180.8 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Infliximab dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), INSULIN (View Insulin Review and Insulin Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), WARFARIN (View Warfarin Review and Warfarin Label ).

6998380-6 | Depression, Headache
Adverse event was reported on Sep 07, 2010 by a Male patient taking Infliximab (View Usage) (Dosage: ) was diagnosed with inflammatory bowel disease and. Location: UNITED STATES , weighting 76.94 lb, After Infliximab was administered, patient had the following side effects: depression (What is depression?), headache (What is headache?). During the same period patient was treated with 5 AMINOSALICYLIC ACID (View 5-aminosalicylic Acid Review and 5-aminosalicylic Acid Label ), PREVACID (View Prevacid Review and Prevacid Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ). Patient was hospitalized.

6985249-6 | Abdominal Pain
on Sep 03, 2010 Female patient from UNITED STATES , weighting 110.7 lb, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Infliximab (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?). Infliximab dosage: . During the same period patient was treated with BUDESONIDE (View Budesonide Review and Budesonide Label ). Patient was hospitalized.


6979042-8 | Crohn's Disease
on Sep 02, 2010 Female patient from UNITED STATES , weighting 78.71 lb, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Infliximab (View Usage). Patient had the following side effects: crohn's disease (What is crohn's disease?). Infliximab dosage: . During the same period patient was treated with HUMIRA (View Humira Review and Humira Label ). Patient was hospitalized.

6978869-6 | Acute Monocytic Leukaemia, Transfusion Reaction
Patient was taking Infliximab (View Usage). After Infliximab was administered, patient had the following side effects: acute monocytic leukaemia, transfusion reaction on Sep 02, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 116.4 lb, was diagnosed with crohn's disease (What is crohn's disease?) and. Infliximab dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), HUMIRA (View Humira Review and Humira Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), IRON (View Iron Review and Iron Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), CHOLECALCIFEROL (View Cholecalciferol Review and Cholecalciferol Label ), PEPTAMEN (View Peptamen Review and Peptamen Label ). Patient was hospitalized.

6972396-8 | Lower Respiratory Tract Infection Fungal
Adverse event was reported on Aug 30, 2010 by a Female patient taking Infliximab (View Usage) (Dosage: 3 Infusions) was diagnosed with colitis ulcerative and. Location: NETHERLANDS , 31 years of age, weighting 143.3 lb, Patient experienced the following unwanted or unexpected effects: lower respiratory tract infection fungal. During the same period patient was treated with PURINETHOL (View Purinethol Review and Purinethol Label ). Patient was hospitalized.

6971018-X | Penis Carcinoma, Positron Emission Tomogram Abnormal, Testicular Mass
on Aug 25, 2010 Male patient from UNITED STATES , weighting 221.0 lb, was diagnosed with psoriasis and was treated with Infliximab (View Usage). Patient had the following side effects: penis carcinoma, positron emission tomogram abnormal, testicular mass. Infliximab dosage: .

6967930-8 | Anaplastic Large Cell Lymphoma T- And Null-cell Types, Crohn's Disease, Hospitalisation, Neck Pain
on Aug 26, 2010 Female patient from UNITED KINGDOM , 68 years of age, was diagnosed with psoriasis, crohn's disease (What is crohn's disease?) and was treated with Infliximab (View Usage). After Infliximab was administered, patient had the following side effects: anaplastic large cell lymphoma t- and null-cell types, crohn's disease (What is crohn's disease?), hospitalisation, neck pain. Infliximab dosage: . During the same period patient was treated with STELARA (View Stelara Review and Stelara Label ). Patient was hospitalized.

6965360-6 | Crohn's Disease
Patient was taking Infliximab (View Usage). Patient experienced the following unwanted or unexpected effects: crohn's disease (What is crohn's disease?) on Aug 26, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 119.7 lb, was diagnosed with crohn's disease (What is crohn's disease?), inflammatory bowel disease and. Infliximab dosage: Prior To Enrollment Into The Study. During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), CIMZIA (View Cimzia Review and Cimzia Label ), CELEXA (View Celexa Review and Celexa Label ), IMODIUM (View Imodium Review and Imodium Label ). Patient was hospitalized.

6965193-0 | Anaplastic Large Cell Lymphoma T- And Null-cell Types, Crohn's Disease, Hospitalisation, Neck Pain
Adverse event was reported on Sep 02, 2010 by a Female patient taking Infliximab (View Usage) (Dosage: ) was diagnosed with psoriasis, crohn's disease (What is crohn's disease?) and. Location: UNITED KINGDOM , 68 years of age, Patient had the following side effects: anaplastic large cell lymphoma t- and null-cell types, crohn's disease (What is crohn's disease?), hospitalisation, neck pain. During the same period patient was treated with STELARA (View Stelara Review and Stelara Label ). Patient was hospitalized.

6964963-2 | Cholangitis Sclerosing
on Aug 25, 2010 Male patient from UNITED STATES , weighting 69.23 lb, was diagnosed with inflammatory bowel disease and was treated with Infliximab (View Usage). After Infliximab was administered, patient had the following side effects: cholangitis sclerosing. Infliximab dosage: . During the same period patient was treated with MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ).

6964863-8 | Lung Neoplasm, Malignant Melanoma, Squamous Cell Carcinoma, Tonsil Cancer
on Aug 24, 2010 Male patient from UNITED STATES , weighting 221.0 lb, was diagnosed with psoriasis and was treated with Infliximab (View Usage). Patient experienced the following unwanted or unexpected effects: lung neoplasm, malignant melanoma, squamous cell carcinoma, tonsil cancer. Infliximab dosage: . During the same period patient was treated with ENBREL (View Enbrel Review and Enbrel Label ).

6956501-5 | Cytomegalovirus Mononucleosis
Patient was taking Infliximab (View Usage). Patient had the following side effects: cytomegalovirus mononucleosis on Aug 16, 2010 from JAPAN Additional patient health information: Female patient , 43 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Infliximab dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ).

6942921-1 | Penis Carcinoma, Positron Emission Tomogram Abnormal, Testicular Mass
Adverse event was reported on Aug 18, 2010 by a Male patient taking Infliximab (View Usage) (Dosage: ) was diagnosed with psoriasis and. Location: UNITED STATES , weighting 221.0 lb, After Infliximab was administered, patient had the following side effects: penis carcinoma, positron emission tomogram abnormal, testicular mass.

6942795-9 | Pneumonia Legionella
on Aug 17, 2010 Female patient from ITALY , 38 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Infliximab (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonia legionella. Infliximab dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ).

6942453-0 | Anaplastic Large Cell Lymphoma T- And Null-cell Types, Crohn's Disease, Hospitalisation, Neck Pain
on Aug 16, 2010 Female patient from UNITED KINGDOM , 68 years of age, was diagnosed with psoriasis, crohn's disease (What is crohn's disease?) and was treated with Infliximab (View Usage). Patient had the following side effects: anaplastic large cell lymphoma t- and null-cell types, crohn's disease (What is crohn's disease?), hospitalisation, neck pain. Infliximab dosage: . During the same period patient was treated with STELARA (View Stelara Review and Stelara Label ).

6942334-2 | Crohn's Disease
Patient was taking Infliximab (View Usage). After Infliximab was administered, patient had the following side effects: crohn's disease (What is crohn's disease?) on Aug 16, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 121.0 lb, was diagnosed with crohn's disease (What is crohn's disease?) and. Infliximab dosage: Started Infliximab In The Fall Of 2008. During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), COLAZAL (Weaned Down From Tid) (View Colazal Review and Colazal Label ), IRON (View Iron Review and Iron Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), CALCIUM (View Calcium Review and Calcium Label ), ACIDOPHILUS (View Acidophilus Review and Acidophilus Label ). Patient was hospitalized.

6942215-4 | Nephrectomy, Renal Cell Carcinoma
Adverse event was reported on Aug 18, 2010 by a Male patient taking Infliximab (View Usage) (Dosage: ) was diagnosed with ankylosing spondylitis (What is ankylosing spondylitis?) and. Location: GREECE , 37 years of age, Patient experienced the following unwanted or unexpected effects: nephrectomy, renal cell carcinoma. During the same period patient was treated with HUMIRA (View Humira Review and Humira Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), FILICINE (View Filicine Review and Filicine Label ).

6941946-X | Lung Neoplasm, Malignant Melanoma, Squamous Cell Carcinoma, Tonsil Cancer
on Aug 18, 2010 Male patient from UNITED STATES , weighting 221.0 lb, was diagnosed with psoriasis and was treated with Infliximab (View Usage). Patient had the following side effects: lung neoplasm, malignant melanoma, squamous cell carcinoma, tonsil cancer. Infliximab dosage: . During the same period patient was treated with ENBREL (View Enbrel Review and Enbrel Label ).

6939278-9 | Pulmonary Sarcoidosis
on Aug 10, 2010 Male patient from ITALY , 34 years of age, was diagnosed with psoriatic arthropathy and was treated with Infliximab (View Usage). After Infliximab was administered, patient had the following side effects: pulmonary sarcoidosis. Infliximab dosage: Started At 0, 2 And 6 Weeks.

6938582-8 | Diarrhoea
Patient was taking Infliximab (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea on Aug 13, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 61 years of age, weighting 216.1 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Infliximab dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ).

6938580-4 | Enterovesical Fistula, Ileostomy Closure, Intestinal Obstruction
Adverse event was reported on Aug 13, 2010 by a Male patient taking Infliximab (View Usage) (Dosage: ) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: UNITED STATES , weighting 119.0 lb, Patient had the following side effects: enterovesical fistula, ileostomy closure, intestinal obstruction. During the same period patient was treated with 5 ASA (View 5-asa Review and 5-asa Label ), BUDESONIDE (View Budesonide Review and Budesonide Label ), PREVACID (View Prevacid Review and Prevacid Label ), HUMIRA (View Humira Review and Humira Label ). Patient was hospitalized.

6938518-X | Anaplastic Large Cell Lymphoma T- And Null-cell Types, Crohn's Disease, Hospitalisation, Neck Pain
on Aug 12, 2010 Female patient from UNITED KINGDOM , 68 years of age, was diagnosed with psoriasis, crohn's disease (What is crohn's disease?) and was treated with Infliximab (View Usage). After Infliximab was administered, patient had the following side effects: anaplastic large cell lymphoma t- and null-cell types, crohn's disease (What is crohn's disease?), hospitalisation, neck pain. Infliximab dosage: . During the same period patient was treated with STELARA (View Stelara Review and Stelara Label ).

6938383-0 | Hepatitis C, Renal Failure Acute, Sepsis
on Aug 13, 2010 Male patient from UNITED STATES , weighting 184.0 lb, was diagnosed with psoriasis and was treated with Infliximab (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis c (What is hepatitis c?), renal failure acute, sepsis (What is sepsis?). Infliximab dosage: . Patient was hospitalized.

6925906-0 | Arthralgia, Back Pain, Bruxism, Erythema, Grimacing, Infusion Related Reaction, Pain In Extremity, Restlessness
Patient was taking Infliximab (View Usage). Patient had the following side effects: arthralgia, back pain (What is back pain?), bruxism, erythema, grimacing, infusion related reaction, pain in extremity, restlessness on Aug 13, 2010 from UNITED STATES Additional patient health information: Male patient , 73 years of age, weighting 211.5 lb, was diagnosed with colitis ulcerative and. Infliximab dosage: 485 Mg Once Iv. Patient was hospitalized.

6925453-6 | Anaplastic Large Cell Lymphoma T- And Null-cell Types, Crohn's Disease, Hospitalisation, Neck Pain
Adverse event was reported on Aug 06, 2010 by a Female patient taking Infliximab (View Usage) (Dosage: ) was diagnosed with psoriasis, crohn's disease (What is crohn's disease?) and. Location: UNITED KINGDOM , 68 years of age, After Infliximab was administered, patient had the following side effects: anaplastic large cell lymphoma t- and null-cell types, crohn's disease (What is crohn's disease?), hospitalisation, neck pain. During the same period patient was treated with STELARA (View Stelara Review and Stelara Label ).

6924835-6 | Abortion Spontaneous
on Aug 04, 2010 Female patient from UNITED KINGDOM , 36 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Infliximab (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous. Infliximab dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ).

6924586-8 | Angina Unstable, Coronary Artery Stenosis
on Aug 04, 2010 Male patient from JAPAN , weighting 149.9 lb, was diagnosed with ankylosing spondylitis (What is ankylosing spondylitis?) and was treated with Infliximab (View Usage). Patient had the following side effects: angina unstable, coronary artery stenosis. Infliximab dosage: 29th Infusion Of Infliximab. Patient was hospitalized.

6922621-4 | Crohn's Disease
Patient was taking Infliximab (View Usage). After Infliximab was administered, patient had the following side effects: crohn's disease (What is crohn's disease?) on Aug 04, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 90.83 lb, was diagnosed with inflammation and. Infliximab dosage: . During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), 5 ASA (View 5-asa Review and 5-asa Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), BACTRIM (View Bactrim Review and Bactrim Label ). Patient was hospitalized.

6913530-5 | Hepatitis C, Renal Failure Acute, Sepsis
Adverse event was reported on Jul 30, 2010 by a Male patient taking Infliximab (View Usage) (Dosage: ) was diagnosed with psoriasis and. Location: UNITED STATES , weighting 184.0 lb, Patient experienced the following unwanted or unexpected effects: hepatitis c (What is hepatitis c?), renal failure acute, sepsis (What is sepsis?). Patient was hospitalized.

6913501-9 | Pulmonary Embolism
on Aug 05, 2010 Female patient from UNITED STATES , weighting 161.4 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Infliximab (View Usage). Patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). Infliximab dosage: 200mg Iv (041). During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6911269-3 | Atrial Fibrillation
on Jul 28, 2010 Male patient from UNITED STATES , weighting 213.0 lb, was diagnosed with psoriasis and was treated with Infliximab (View Usage). After Infliximab was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?). Infliximab dosage: . During the same period patient was treated with STELARA (View Stelara Review and Stelara Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

6910669-5 | Hypopharyngeal Cancer
Patient was taking Infliximab (View Usage). Patient experienced the following unwanted or unexpected effects: hypopharyngeal cancer on Jul 27, 2010 from GERMANY Additional patient health information: Female patient , 76 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Infliximab dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), TRAMUNDIN RETARD (View Tramundin Retard Review and Tramundin Retard Label ). Patient was hospitalized and became disabled.

6886898-6 | Acute Monocytic Leukaemia, Transfusion Reaction
Adverse event was reported on Jul 20, 2010 by a Male patient taking Infliximab (View Usage) (Dosage: ) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: UNITED STATES , weighting 116.4 lb, Patient had the following side effects: acute monocytic leukaemia, transfusion reaction. During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), HUMIRA (View Humira Review and Humira Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), IRON (View Iron Review and Iron Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), CHOLECALCIFEROL (View Cholecalciferol Review and Cholecalciferol Label ), PEPTAMEN (View Peptamen Review and Peptamen Label ). Patient was hospitalized.

6881926-6 | Cytomegalovirus Mononucleosis
on Jul 20, 2010 Female patient from JAPAN , 43 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Infliximab (View Usage). After Infliximab was administered, patient had the following side effects: cytomegalovirus mononucleosis. Infliximab dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ).

6875369-9 | Crohn's Disease
on Jul 14, 2010 Male patient from UNITED STATES , weighting 27.56 lb, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Infliximab (View Usage). Patient experienced the following unwanted or unexpected effects: crohn's disease (What is crohn's disease?). Infliximab dosage: . Patient was hospitalized.

6875282-7 | Ascites, Crohn's Disease, Urinary Retention
Patient was taking Infliximab (View Usage). Patient had the following side effects: ascites, crohn's disease (What is crohn's disease?), urinary retention on Jul 15, 2010 from UNITED KINGDOM Additional patient health information: Female patient , weighting 88.63 lb, was diagnosed with inflammatory bowel disease and. Infliximab dosage: . During the same period patient was treated with HUMIRA (View Humira Review and Humira Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), ANTIBIOTIC (View Antibiotic Review and Antibiotic Label ), MORPHINE (View Morphine Review and Morphine Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), CALCICHEW (View Calcichew Review and Calcichew Label ). Patient was hospitalized.

6871928-8 | Chest Discomfort, Dyspnoea, Infusion Related Reaction, Throat Tightness, Urticaria
Adverse event was reported on Jul 12, 2010 by a Female patient taking Infliximab (View Usage) (Dosage: ) was diagnosed with inflammatory bowel disease and. Location: UNITED STATES , weighting 80.25 lb, After Infliximab was administered, patient had the following side effects: chest discomfort, dyspnoea, infusion related reaction, throat tightness, urticaria. During the same period patient was treated with AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), ZINC (View Zinc Review and Zinc Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), CALCIUM (View Calcium Review and Calcium Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), BENADRYL (View Benadryl Review and Benadryl Label ).

6866918-5 | Atrial Fibrillation
on Jul 12, 2010 Male patient from UNITED STATES , weighting 213.0 lb, was diagnosed with psoriasis and was treated with Infliximab (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?). Infliximab dosage: . During the same period patient was treated with STELARA (View Stelara Review and Stelara Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

6863152-X | Crohn's Disease
on Jul 06, 2010 Female patient from UNITED KINGDOM , weighting 88.63 lb, was diagnosed with inflammatory bowel disease and was treated with Infliximab (View Usage). Patient had the following side effects: crohn's disease (What is crohn's disease?). Infliximab dosage: . During the same period patient was treated with HUMIRA (View Humira Review and Humira Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), ANTIBIOTIC (View Antibiotic Review and Antibiotic Label ), MORPHINE (View Morphine Review and Morphine Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), CALCICHEW (View Calcichew Review and Calcichew Label ). Patient was hospitalized.

6862143-2 | Abdominal Pain, Gastrointestinal Fistula, Infection
Patient was taking Infliximab (View Usage). After Infliximab was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), gastrointestinal fistula, infection (What is infection?) on Jul 06, 2010 from UNITED KINGDOM Additional patient health information: Female patient , weighting 88.63 lb, was diagnosed with inflammatory bowel disease and. Infliximab dosage: . During the same period patient was treated with HUMIRA (View Humira Review and Humira Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), ANTIBIOTIC (View Antibiotic Review and Antibiotic Label ), MORPHINE (View Morphine Review and Morphine Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), CALCICHEW (View Calcichew Review and Calcichew Label ). Patient was hospitalized.

6862142-0 | Crohn's Disease
Adverse event was reported on Jul 16, 2010 by a Male patient taking Infliximab (View Usage) (Dosage: ) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: UNITED STATES , weighting 162.0 lb, Patient experienced the following unwanted or unexpected effects: crohn's disease (What is crohn's disease?). During the same period patient was treated with 5 ASA (View 5-asa Review and 5-asa Label ), MERCAPTOPURINE (View Mercaptopurine Review and Mercaptopurine Label ), CALCIUM WITH VITAMIN D (View Calcium With Vitamin D Review and Calcium With Vitamin D Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), IRON (View Iron Review and Iron Label ).

6861109-6 | Anal Abscess, Anal Fistula
on Jul 08, 2010 Male patient from GERMANY , weighting 73.63 lb, was diagnosed with inflammatory bowel disease and was treated with Infliximab (View Usage). Patient had the following side effects: anal abscess, anal fistula. Infliximab dosage: . During the same period patient was treated with 5 ASA (View 5-asa Review and 5-asa Label ). Patient was hospitalized.

6861108-4 | Crohn's Disease
on Jul 08, 2010 Female patient from FRANCE , weighting 102.5 lb, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Infliximab (View Usage). After Infliximab was administered, patient had the following side effects: crohn's disease (What is crohn's disease?). Infliximab dosage: . During the same period patient was treated with HUMIRA (View Humira Review and Humira Label ), BUDESONIDE (View Budesonide Review and Budesonide Label ). Patient was hospitalized.

6860666-3 | Hypersensitivity, Infusion Related Reaction, Respiratory Distress
Patient was taking Infliximab (View Usage). Patient experienced the following unwanted or unexpected effects: hypersensitivity, infusion related reaction, respiratory distress on Jul 08, 2010 from FRANCE Additional patient health information: Female patient , weighting 69.67 lb, was diagnosed with inflammatory bowel disease and. Infliximab dosage: . During the same period patient was treated with AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ).

6860656-0 | Lupus-like Syndrome
Adverse event was reported on Jul 08, 2010 by a Male patient taking Infliximab (View Usage) (Dosage: ) was diagnosed with inflammatory bowel disease and. Location: GERMANY , weighting 141.1 lb, Patient had the following side effects: lupus-like syndrome. During the same period patient was treated with AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), 5 ASA (View 5-asa Review and 5-asa Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6860655-9 | Crohn's Disease, Mental Disorder
on Jul 08, 2010 Male patient from GERMANY , weighting 160.7 lb, was diagnosed with inflammatory bowel disease and was treated with Infliximab (View Usage). After Infliximab was administered, patient had the following side effects: crohn's disease (What is crohn's disease?), mental disorder. Infliximab dosage: . During the same period patient was treated with 5 ASA (View 5-asa Review and 5-asa Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ). Patient was hospitalized.

6860654-7 | Crohn's Disease, Mental Disorder
on Jul 08, 2010 Male patient from GERMANY , weighting 160.7 lb, was diagnosed with inflammatory bowel disease and was treated with Infliximab (View Usage). Patient experienced the following unwanted or unexpected effects: crohn's disease (What is crohn's disease?), mental disorder. Infliximab dosage: . During the same period patient was treated with 5 ASA (View 5-asa Review and 5-asa Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ). Patient was hospitalized.

6859907-8 | Anal Abscess, Anal Fistula
Patient was taking Infliximab (View Usage). Patient had the following side effects: anal abscess, anal fistula on Jul 08, 2010 from GERMANY Additional patient health information: Male patient , weighting 73.63 lb, was diagnosed with inflammatory bowel disease and. Infliximab dosage: . During the same period patient was treated with 5 ASA (View 5-asa Review and 5-asa Label ). Patient was hospitalized.